Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012... Show more
Mondelez International shares have staged a steady recovery through the second half of 2026. After pulling back toward the $57 range in early October, the stock rebounded to close near $63.80 in late October, leaving it up roughly 4% over the trailing 30 days and about 6% over the quarter. On a year-to-date basis, MDLZ has advanced roughly 17%, outpacing a challenging stretch for the broader packaged-food industry.
The stock's trajectory reflects a tug-of-war between two forces: persistent input-cost pressure, particularly cocoa, and resilient global demand for branded snacks. Investor sentiment has improved as commodity costs show signs of easing, while analysts have largely maintained favorable ratings. The result is a measured, fundamentals-driven recovery rather than a speculative rally.
Mondelez International is one of the world's largest snack-food companies, with a portfolio built around biscuits and baked snacks, chocolate, gum and candy, and beverages. Iconic global and local brands include Oreo, Cadbury Dairy Milk, Ritz, Toblerone, Milka, Chips Ahoy!, belVita, Triscuit, Sour Patch Kids, and Halls. The company operates roughly 145 manufacturing sites and employs about 91,000 people worldwide.
Geographically, Mondelez is highly diversified, with Europe, North America, Asia, the Middle East, Africa, and Latin America all contributing meaningfully to revenue. This global footprint—combined with leadership positions in core snacking categories—gives the company significant pricing power and scale. Investors follow MDLZ for its defensive, consumer-staples profile, strong brand equity, and its ability to manage input-cost cycles while sustaining dividends and buybacks.
Several verified developments have shaped MDLZ's recent performance. In its first-quarter 2026 results, Mondelez posted adjusted earnings per share of $0.67, above the consensus estimate of $0.61, on revenue of $10.08 billion that also beat expectations. The stock rallied on the print, aided by 3% organic revenue growth and an 11.3% organic gain in the Asia, Middle East, and Africa region.
Cocoa costs remain the central story. Prices spiked sharply in early 2025 and have since declined by roughly 70% from their peak, but the phasing of high-cost inventory continued to pressure margins into mid-2026. Management has pointed to gradual normalization, and in the second quarter adjusted gross margin still expanded 20 basis points to 34%, even as adjusted operating income declined at constant currency.
Mondelez also raised its 2026 organic net revenue growth outlook to at least 2%, up from flat to 2%, reflecting improving volume and regional momentum. On the analyst front, Barclays raised its price target to $72, Bernstein maintained a Buy with a $74 target, and JPMorgan trimmed its target to $71 while keeping an Overweight rating. Brand initiatives—including a first-ever partnership with the Kansas City Chiefs and limited-time collaborations such as Oreo with Portillo's—have added visibility without materially altering near-term financials.
Tickeron's Trending AI Robots page curates a selection of AI-driven trading bots that monitor markets across thousands of tickers. While Tickeron offers hundreds of automated strategies, only the top-performing and most relevant bots appear in this featured section. The bots vary in trading style, timeframe, and performance metrics, giving traders a way to compare different automated approaches in one place. For investors tracking consumer-staples names like Mondelez, exploring these curated strategies can offer an additional, data-driven perspective on market signals.
Looking ahead, the trajectory of cocoa costs will be the single most important factor for Mondelez's margins. If the gradual normalization continues, earnings should benefit as higher-cost inventory works through the system. Conversely, any renewed spike in cocoa, or sustained energy and packaging inflation tied to geopolitical tensions, could pressure profitability.
Investors should also monitor North American volume recovery, which has lagged amid cautious consumer spending, as well as the pace of emerging-market expansion, where Mondelez continues to gain share. Brand reinvestment, innovation, and distribution gains in channels such as club and convenience stores are additional drivers. With a consensus Buy rating and an average price target in the high $60s, the market's focus will remain on whether pricing power and cost discipline translate into a sustained earnings rebound.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for MDLZ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 27 of 56 cases where MDLZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 48%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on MDLZ as a result. In 46 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.
The Moving Average Convergence Divergence (MACD) for MDLZ just turned positive on October 30, 2026. Looking at past instances where MDLZ's MACD turned positive, the stock continued to rise in 18 of 44 cases over the following month. The odds of a continued upward trend are 41%.
MDLZ moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in 166 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for MDLZ moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 19 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for MDLZ entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.111) is normal, around the industry mean (1.474). P/E Ratio (23.787) is within average values for comparable stocks, (14.685). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.364). Dividend Yield (0.032) settles around the average of (0.160) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (1.937).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of packaged food products
Industry FoodSpecialtyCandy